Annex IV contributes to consumer safety by ensuring that only substances with a well-established safety profile are exempt from rigorous testing. This helps maintain high safety standards for consumer products while allowing for innovation and the use of benign substances in manufacturing. By reducing the regulatory burden for these substances, companies can focus on developing safer products for consumers.
